TITLE:
Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer

CONDITION:
Breast Cancer

INTERVENTION:
Pemetrexed

SUMMARY:

      This is a nonrandomized study of pemetrexed plus carboplatin, with the primary objective of
      determining the efficacy of the combination in tumor reduction, in patients with locally
      advanced or metastatic breast cancer.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: Female
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Histologic or cytologic diagnosis of locally advanced or metastatic breast cancer

          -  No prior chemotherapy for locally advanced or metastatic breast disease.

          -  Patient may have received prior adjuvant therapy finished greater than 1 year prior
             to enrollment.

          -  Adequate bone marrow, liver and kidney function

          -  RECIST criteria for disease status

        Exclusion Criteria:

          -  Prior treatment with pemetrexed

          -  Pregnant or breast feeding

          -  Brain Metastasis

          -  unable or unwilling to take folic acid, vitamin B12 supplementation, or
             dexamethasone.
      
